Dow Up 2.00% Nasdaq Up 1.66%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
0.19 Up 0.01(3.21%) Feb 12, 4:00PM EST
Prev Close:0.19
Open:0.19
Bid:0.16 x 30000
Ask:0.20 x 100
1y Target Est:8.00
Beta:0.774722
Next Earnings Date:N/A
Day's Range:0.19 - 0.20
52wk Range:0.15 - 3.17
Volume:706,711
Avg Vol (3m):1,637,640
Market Cap:26.59M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTAUp 3.21%26.59M
INFIUp 6.47%291.45M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.63
Quarterly EPS Est (Dec-15) :-0.16
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback